Stoke Therapeutics, Inc. (STOK) stock forecast and price target
Price $26.68 · data as of November 13, 2026
12-month price target
Average target$46.38
Upside / downside+73.9%
Analysts13
ConsensusStrong buy
Low $35.00Average $46.38High $60.00
Gold marker: average target · white marker: today’s price ($26.68)
Analyst ratings
Strong buy 2Buy 12Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-4.01 | −3243.2% | $35M |
| Next fiscal year ends December 31, 2027 | $-4.09 | −1.8% | $47M |
| Next quarter ends December 31, 2026 | $-1.19 | −22.3% | $7M |
| Quarter after ends March 31, 2027 | $-1.19 | −50.5% | $7M |
Consensus of the analysts covering Stoke Therapeutics, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.
Frequently asked questions
What is the Stoke Therapeutics stock price target?
The average 12-month target from 13 analysts is $46.38, 73.9% above the current price of $26.68 Targets range from $35.00 to $60.00.
Is Stoke Therapeutics a buy according to analysts?
The consensus rating is “Strong buy” (2 strong buy, 12 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Stoke Therapeutics expected to earn?
Analysts expect EPS of $-4.01 for the fiscal year ending December 31, 2026 and $-4.09 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.